Journal of clinical microbiology
COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme.
C-Reactive Protein for Active Tuberculosis Among Inpatients without HIV in Uganda: A Diagnostic Accuracy Study.
Direct Comparison of SARS-CoV-2 Analytical Limits of Detection across Seven Molecular Assays.
Should we be performing metagenomic next-generation sequencing for infectious disease diagnosis in the clinical laboratory?
Molecular characterization of methicillin-resistant Staphylococcus aureus clinical isolates obtained from the Rikers Island Jail System from 2009 to 2013.
Metagenomic Next-Generation Sequencing of the 2014 Ebola Virus Disease Outbreak in the Democratic Republic of the Congo.
Simultaneous runs of the Bayer VERSANT HIV-1 version 3.0 and HCV bDNA version 3.0 quantitative assays on the system 340 platform provide reliable quantitation and improved work flow.
Evaluation of the Binax NOW, BD Directigen, and BD Directigen EZ assays for detection of respiratory syncytial virus.
Evaluation of the VACUTAINER PPT Plasma Preparation Tube for use with the Bayer VERSANT assay for quantification of human immunodeficiency virus type 1 RNA.
False-positive culture results from patient tissue specimens due to contamination of RPMI medium with Cryptococcus albidus.
